Vanda Pharmaceuticals buy Truist Financial Co.
Start price
05.03.26
/
50%
€6.80
Target price
05.03.27
€15.49
Performance (%)
-13.46%
Price
24.04.26
€5.89
Summary
This prediction is currently active. The price of Vanda Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.46%. This prediction currently runs until 05.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -4.696% | -4.696% |
| iShares Core DAX® | -1.741% | 5.979% |
| iShares Nasdaq 100 | 2.815% | 11.827% |
| iShares Nikkei 225® | -0.109% | 11.692% |
| iShares S&P 500 | 0.966% | 7.616% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat